SPI Infoamtion

このレポートは章ごとの個別販売も行っておりますのでお問い合わせ下さい。
※全てPDFでの販売となります。

Chapter- 1: SUMMARY

AGING POPULATIONS AND CHRONIC DISEASES
OVERALL GLOBAL PHARMACEUTICAL MARKETS
SUMMARY TABLE WORLDWIDE MARKET PHARMACEUTICAL PRODUCTS, THROUGH 2013 ($ BILLIONS)
SUMMARY FIGURE WORLDWIDE MARKET PHARMACEUTICAL PRODUCTS, 2006-2013 ($ BILLIONS)

Chapter- 2: OVERVIEW

BACKGROUND ON THE INDUSTRY
RECENT HISTORY
BENEFITS, PROBLEMS, AND REGULATION
CHANGES IN THE INDUSTRY
HEALTHCARE EXPENDITURES
TABLE 1 HEALTHCARE EXPENDITURES, COUNTRIES IN THIS REPORT, 2000 AND 2005 (% OF GDP)

Chapter- 3: THE PHARMACEUTICAL INDUSTRY

TABLE 2 WORLDWIDE LEADING ETHICAL PHARMACEUTICAL COMPANIES: SALES AND MARKET SHARE, 2006 AND 2007 ($ BILLIONS)
RESEARCH AND DEVELOPMENT EXPENDITURES
TABLE 3 WORLDWIDE LEADING PHARMACEUTICAL COMPANIES BY R&D SPENDING, 2006 AND 2007 ($ BILLIONS)
SECTOR PERFORMANCE
BRANDED PHARMACEUTICALS
TABLE 4 LARGEST PHARMACEUTICAL MARKETS (OVERALL), 2006 AND 2007 ($ BILLIONS, % OF TOTAL)
TABLE 5 LARGEST PHARMACEUTICAL MARKETS (BRANDED), 2006 AND 2007 ($ BILLIONS, % OF TOTAL)
TABLE 6 WORLDWIDE LEADING PHARMACEUTICAL LARGEST PHARMACEUTICAL MARKETS (GENERIC), 2006 AND 2007 ($ BILLIONS, % OF TOTAL)
TABLE 7 LARGEST PHARMACEUTICAL MARKETS (OTC), 2006 AND 2007 ($ BILLIONS, % OF TOTAL)

Chapter- 4: UNITED STATES

INTRODUCTION
TABLE 8 OVERALL PHARMACEUTICAL MARKET, U.S., THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 9 POPULATION TRENDS, U.S., THROUGH 2013 (MILLIONS)
FIGURE 1 U.S. POPULATION, 1998-2013 (MILLIONS)
TABLE 10 DEMOGRAPHIC TRENDS, U.S., THROUGH 2013 (MILLIONS)
THE U.S. HEALTHCARE SYSTEM
HEALTHCARE EXPENDITURES IN THE U.S.
FIGURE 2 U.S. HEALTHCARE EXPENDITURES, 1980-2006 ($ BILLIONS)
TABLE 11 HEALTHCARE EXPENDITURE, U.S., 2000 AND 2006
TABLE 12 MOST EXPENSIVE MEDICAL CONDITIONS, U.S., 2004 ($ BILLIONS, %)
TABLE 13 PRESCRIPTION DRUG EXPENDITURES BY CATEGORY, 2006 ($ BILLIONS)
COMMON HEALTH PROBLEMS IN THE U.S.
TABLE 14 LEADING CAUSES OF DEATH, U.S. 1997-2005 (%)
ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS
OBESITY AND RELATED CONDITIONS
DIABETES
CARDIOVASCULAR DISEASE
TABLE 15 CARDIOVASCULAR DISEASE, U.S., 2005 (%)
SMOKING
CANCER
TABLE 16 INVASIVE CANCER, U.S., 2004 (%)
TABLE 17 CANCER DEATHS, U.S., 2004 (%)
TABLE 18 CANCER DEATHS, U.S., 2004 (RATIO OF DEATHS: NEW CASES)
HIV INFECTION
GOVERNMENT REGULATIONS
INTRODUCTION
DRUG DISCOVERY
Preclinical Testing and Submission of an IND
CLINICAL TRIALS
TIMELINE AND COSTS
SUBMISSION OF AN NDA OR BLA
POST-FDA APPROVAL
NEW DRUG APPROVALS
FIGURE 3 NME APPROVALS, 1997-2007
FIGURE 4 NME APPROVALS IN TWO SEVEN-YEAR PERIODS, 1994-2007
TABLE 19 NEW MOLECULAR ENTITIES APPROVED BY THE FDA, 1980 TO MARCH 20, 2007
DO CURRENT CORPORATE MANAGEMENT PRACTICES HAVE A ROLE IN R&D SHORTFALLS?
BLOCKBUSTER DRUGS
TABLE 20 NME APPROVALS BY DISORDER, 2004--MARCH 20, 2008
OTHER SUCCESSFUL THERAPEUTIC AGENTS
TABLE 21 BOTOX SALES, 1993-2012 ($ MILLIONS)
IS THE NIH FUNDING CRISIS CONTRIBUTING TO SHORTFALLS IN DRUG DISCOVERY?
PHARMACEUTICAL PRICING
FACTORS AFFECTING DRUG PRICES
PHARMACY BENEFIT MANAGERS (PBMS)
TABLE 22 MARKET SHARE: PHARMACY BENEFIT MANAGERS, 2007 (%)
PHARMACEUTICAL FLOW FROM MANUFACTURER TO PATIENT
PHARMACEUTICAL WHOLESALING
TABLE 23 MARKET SHARE: U.S. WHOLESALERS, 2007 (%, $ BILLIONS)
PHARMACEUTICAL RETAILING
TABLE 24 LEADING DRUG RETAILERS RX VOLUME, U.S., 2002 AND 2007 (RX MILLIONS)
EXPORT--IMPORT PROFILE
TABLE 25 EXPORT--IMPORT PROFILE, U.S., 1995--2006 ($ BILLIONS)
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 26 BRANDED PHARMACEUTICAL MARKET, U.S., THROUGH 2013 ($ BILLIONS)
TABLE 27 TOP 10 SELLING U.S. DRUGS, 2006 AND 2007 ($ BILLIONS)
GENERIC DRUGS
TABLE 28 GENERIC PRESCRIPTION PHARMACEUTICAL MARKET, U.S., THROUGH 2013 ($ BILLIONS)
OVER-THE-COUNTER (OTC) MEDICATIONS IN THE U.S.
TABLE 29 OTC PHARMACEUTICAL MARKET, U.S., THROUGH 2013 ($ BILLIONS)
IMPORTANT ORGANIZATIONS IN THE U.S.
PHRMA, THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
GPHA, GENERIC PHARMACEUTICAL ASSOCIATION
CHPA (CONSUMER HEALTHCARE PRODUCTS ASSOCIATION)
COMPANY PROFILES: UNITED STATES
ABBOTT LABORATORIES
BIOGEN IDEC
AMGEN
BRISTOL-MYERS SQUIBB
FOREST LABORATORIES
GENENTECH
GENZYME
JOHNSON & JOHNSON
ELI LILLY AND COMPANY
MERCK & CO. INC.
PFIZER
WYETH PHARMACEUTICALS
TEVA PHARMACEUTICALS
Teva North America

Chapter- 5: CANADA

INTRODUCTION
TABLE 30 OVERALL PHARMACEUTICAL MARKET, CANADA, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 31 POPULATION TRENDS, CANADA, THROUGH 2013 (MILLIONS)
FIGURE 5 CANADA: POPULATION 1998-2013 (MILLIONS)
TABLE 32 DEMOGRAPHIC TRENDS, CANADA, THROUGH 2013 (MILLIONS)
THE CANADIAN HEALTHCARE SYSTEM
HEALTHCARE EXPENDITURE IN CANADA
TABLE 33 HEALTHCARE EXPENDITURE: CANADA, 2000 AND 2005
COMMON HEALTH PROBLEMS IN CANADA
ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
OBESITY AND RELATED CONDITIONS
DIABETES
CARDIOVASCULAR DISEASE AND CANCER
HIV INFECTION
PHARMACEUTICAL PRICING
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 34 BRANDED PHARMACEUTICAL MARKET, CANADA, THROUGH 2013 ($ BILLIONS)
GENERIC DRUGS
TABLE 35 GENERIC PHARMACEUTICAL MARKET, CANADA, THROUGH 2013 ($ BILLIONS)
OVER-THE-COUNTER (OTC) MEDICATIONS IN CANADA
TABLE 36 OTC PHARMACEUTICAL MARKET, CANADA, THROUGH 2013 ($ BILLIONS)
TABLE 37 TOP SELLING CATEGORIES OF OTC MEDICATIONS IN CANADA (%)
IMPORTANT ORGANIZATIONS IN CANADA
STATISTICS CANADA
RX&D, CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES
CGPA (CANADIAN GENERIC PHARMACEUTICAL ASSOCIATION)
NDMAC (THE NONPRESCRIPTION DRUG MANUFACTURERS ASSOCIATION OF CANADA)
COMPANY PROFILES: CANADA
ABBOTT LABORATORIES, LIMITED
ACTELION
ASTRAZENECA CANADA INC.
BAYER, INC.
BRISTOL-MYERS SQUIBB CANADA
ELI LILLY CANADA INC.
GLAXOSMITHKLINE INC.
HOFFMANN-LA ROCHE LIMITED
LUNDBECK CANADA INC.
MERCK FROSST CANADA LTD.
NOVARTIS PHARMACEUTICALS CANADA INC.
PFIZER CANADA INC.
PURDUE PHARMA (1956)
SANOFI-AVENTIS CANADA
SOLVAY PHARMA INC
WYETH PHARMACEUTICALS

Chapter- 6: MEXICO

INTRODUCTION
TABLE 38 OVERALL PHARMACEUTICAL MARKET, MEXICO, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 39 POPULATION TRENDS, MEXICO, THROUGH 2013 (MILLIONS)
THE MEXICAN HEALTHCARE SYSTEM
HEALTHCARE EXPENDITURE IN MEXICO
TABLE 40 HEALTHCARE EXPENDITURE: MEXICO, 2000-2005
COMMON HEALTH PROBLEMS IN MEXICO
OBESITY AND RELATED CONDITIONS
DIABETES: THE LEADING CAUSE OF DEATH
HIV INFECTION
PHARMACEUTICAL REGULATION AND PRICING
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 41 BRANDED PHARMACEUTICAL MARKET, MEXICO, THROUGH 2013 ($ BILLIONS)
GENERIC DRUGS
TABLE 42 GENERIC PHARMACEUTICAL MARKET, MEXICO, THROUGH 2013 ($ BILLIONS)
OVER-THE-COUNTER (OTC) MEDICATIONS IN MEXICO
TABLE 43 OTC PHARMACEUTICAL MARKET, MEXICO, THROUGH 2013 ($ BILLIONS)
IMPORTANT ORGANIZATIONS IN MEXICO
STATISTICS MEXICO: SISTEMAS NACIONALES ESTADI'STICO Y DE INFORMACIO'N GEOGRA'FICA (SNEIG)
AFAMELA (ASOCIACION DE FABRICANTES DE MEDICAMENTOS DE LIBRE ACCESO AC)
AMIIF (ASOCIACIO'N MEXICANA DE INDUSTRIALES DE INVESTIGACIO'N FARMACE'UTIA A.C., MEXICAN ASSOCIATION OF PHARMACEUTICAL COMPANIES)
CANIFARMA (CAMARA NACIONAL DE LA INDUSTRIA FARMACEUTICA)
FIFARMA, THE LATIN AMERICAN FEDERATION OF THE PHARMACEUTICAL INDUSTRY
ILAR (INDUSTRIO LATINOAERMICANA DE AUTOMEDICACION RESPONSABLE)

Chapter- 7: BRAZIL

INTRODUCTION
TABLE 44 OVERALL PHARMACEUTICAL MARKET, BRAZIL, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 45 POPULATION TRENDS, BRAZIL, THROUGH 2013 (MILLIONS)
HEALTHCARE AND HEALTH PROBLEMS IN BRAZIL
THE HEALTHCARE SYSTEM (MEDICARE)
PHARMACEUTICAL PRICING
HEALTH PROBLEMS IN BRAZIL
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 46 BRANDED PHARMACEUTICAL MARKET, BRAZIL, THROUGH 2013 ($ BILLIONS)
GENERIC DRUGS
TABLE 47 GENERIC PHARMACEUTICAL MARKET, BRAZIL, THROUGH 2013 ($ BILLIONS)
OVER-THE-COUNTER MEDICATIONS
TABLE 48 OTC PHARMACEUTICAL MARKET, BRAZIL, THROUGH 2013 ($ MILLIONS)
IMPORTANT ORGANIZATIONS IN BRAZIL
BRAZILIAN INSTITUTE OF GEOGRAPHY AND STATISTICS

Chapter- 8: EUROPE

HEALTHCARE IN EUROPE
REIMBURSEMENT OF PHARMACEUTICALS
POPULATION DEMOGRAPHICS IN EUROPE
POPULATION GROWTH, MEDIAN AGE, AND LIFE EXPECTANCY
EXCESS WEIGHT
LIFE EXPECTANCY IN EUROPE
PHARMACEUTICAL MARKETS IN EUROPE
TABLE 49 TOP FIVE PHARMACEUTICAL MARKETS, EUROPE, THROUGH 2013 ($ BILLIONS)
PROPRIETARY PRESCRIPTION MEDICATIONS (ALSO CALLED BRANDED MEDICATIONS AND ETHICAL PHARMACEUTICALS)
TABLE 50 BRANDED PRESCRIPTION PHARMACEUTICALS MARKET BY VALUE, EUROPE, THROUGH 2013 ($ BILLIONS)
DATA EXCLUSIVITY
GENERIC MEDICATIONS
TABLE 51 GENERIC PHARMACEUTICALS MARKET BY VALUE, EUROPE, THROUGH 2013 ($ BILLIONS)
GENERIC SMALL MOLECULES
BIOSIMILARS
OVER-THE-COUNTER MEDICATIONS
TABLE 52 OTC PHARMACEUTICALS MARKET BY VALUE, EUROPE, THROUGH 2013 ($ BILLIONS)

Chapter- 9: FRANCE

INTRODUCTION
TABLE 53 OVERALL PHARMACEUTICAL MARKET, FRANCE, THROUGH 2013 ($ BILLIONS)
DRIVERS OF PHARMACEUTICAL SALES GROWTH
POPULATION AND DEMOGRAPHICS
TABLE 54 POPULATION TRENDS, FRANCE, THROUGH 2013 (MILLIONS)
FIGURE 6 FRANCE: POPULATION, 1998-2013 (MILLIONS)
TABLE 55 DEMOGRAPHIC TRENDS, FRANCE, THROUGH 2013 (MILLIONS)
HEALTHCARE EXPENDITURE IN FRANCE
TABLE 56 HEALTHCARE EXPENDITURE: FRANCE, 2000-2005
COMMON HEALTH PROBLEMS IN FRANCE
ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
TABLE 57 DEMENTIA IN FRANCE, 2005-2050 (MILLIONS OF PEOPLE)
OBESITY AND RELATED CONDITIONS
DIABETES
CARDIOVASCULAR DISEASE
TABLE 58 PERCENTAGE OF SPENDING ON PHARMACEUTICALS BY CLASS, FRANCE, 2006 (%)
PHARMACEUTICAL PRICING
FIGURE 7 VALUE BREAKDOWN OF PHARMACEUTICALS, FRANCE, 2005 (%)
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 59 BRANDED PHARMACEUTICAL MARKET, FRANCE, THROUGH 2013 ($ BILLIONS)
GENERIC DRUGS
TABLE 60 GENERIC PHARMACEUTICAL MARKET, FRANCE, THROUGH 2013 ($ BILLIONS)
FIGURE 8 LEADING GENERIC MANUFACTURERS, MARKET SHARE, FRANCE, 2006 (% SHARE)
DRIVERS AND RESTRAINTS
OVER-THE-COUNTER (OTC) MEDICATIONS IN FRANCE
TABLE 61 OTC PHARMACEUTICAL MARKET, FRANCE, THROUGH 2013 ($ BILLIONS)
TABLE 62 REASONS FOR ADULT PURCHASES OF OTC MEDICATIONS IN FRANCE (%)
EXPORT--IMPORT PROFILE
TABLE 63 PHARMACEUTICAL EXPORTS, FRANCE, 2000 AND 2006 ($ BILLIONS)
TABLE 64 PHARMACEUTICAL IMPORTS, FRANCE, 2005 AND 2006 ($ BILLIONS)
PHARMACEUTICAL DISTRIBUTION
WHOLESALERS
FIGURE 9 LEADING WHOLESALERS MARKET SHARE, FRANCE, 2006--2007 (% SHARE)
FRANCE'S PHARMACEUTICAL EXPORTS AND IMPORTS IN EUROS
TABLE 65 PHARMACEUTICAL EXPORTS, FRANCE, 2000 AND 2006 (EUROS, MILLIONS)
TABLE 66 PHARMACEUTICAL IMPORTS, FRANCE, 2005 AND 2006 (EUROS, MILLIONS)
IMPORTANT ORGANIZATIONS IN FRANCE
INSEE (NATIONAL INSTITUTE FOR STATISTICS AND ECONOMIC STUDIES)
LEEM, THE FRENCH PHARMACEUTICAL COMPANIES ASSOCIATION
CSRP (SYNDICATE OF PHARMACEUTICAL DISTRIBUTORS:
FRANCE ALZHEIMER:
COMPANY PROFILES: FRANCE
BIOGARAN
CERP
MERCK GENERIQUES
SANDOZ: (SEE GERMANY)
SANOFI-AVENTIS

Chapter- 10: GERMANY

INTRODUCTION
TABLE 67 OVERALL PHARMACEUTICAL MARKET, GERMANY, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 68 POPULATION TRENDS, GERMANY, THROUGH 2013 (MILLIONS)
TABLE 69 DEMOGRAPHIC TRENDS, GERMANY, THROUGH 2013 (MILLIONS)
FIGURE 10 GERMANY: POPULATION 1998-2013 (MILLIONS)
THE GERMAN HEALTHCARE SYSTEM
HEALTHCARE EXPENDITURE IN GERMANY
TABLE 70 HEALTHCARE EXPENDITURE: GERMANY, 2000-2005
COMMON HEALTH PROBLEMS IN GERMANY
ALZHEIMER'S DISEASE AND RELATED DEMENTIAS
TABLE 71 DEMENTIA IN GERMANY, 2005-2050 (MILLIONS OF PEOPLE)
OBESITY AND RELATED CONDITIONS
DIABETES
CARDIOVASCULAR DISEASE
TABLE 72 EXPENDITURES BY THERAPY AREA, GERMANY (PERCENTAGE OF HEALTHCARE SPENDING, ROUNDED)
PRICING AND REIMBURSEMENT OF PHARMACEUTICAL AGENTS
FIGURE 11 VALUE BREAKDOWN OF PHARMACEUTICALS, GERMANY, 2005 (%)
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 73 BRANDED PHARMACEUTICAL MARKET, GERMANY, THROUGH 2013 ($ BILLIONS)
GENERIC DRUGS
TABLE 74 GENERIC PHARMACEUTICAL MARKET, GERMANY, THROUGH 2013 ($ BILLIONS)
DRIVERS AND RESTRAINTS
OVER-THE-COUNTER MEDICATIONS
TABLE 75 OTC PHARMACEUTICAL MARKET, GERMANY, THROUGH 2013 ($ BILLIONS)
TABLE 76 LEADING OTC PRODUCTS, GERMANY, 2006 (%)
PHARMACEUTICAL DISTRIBUTION
WHOLESALERS
FIGURE 12 LEADING WHOLESALERS MARKET SHARE, GERMANY, 2006--2007 (% SHARE)
GERMAN PHARMACEUTICAL EXPORTS AND IMPORTS IN EUROS
TABLE 77 PHARMACEUTICAL EXPORTS, GERMANY, 2005 AND 2006 (EUROS, MILLIONS)
TABLE 78 PHARMACEUTICAL IMPORTS, GERMANY, 2005 AND 2006 (EUROS, MILLIONS)
IMPORTANT ORGANIZATIONS IN GERMANY
DESTATIS (FEDERAL STATISTICAL OFFICE)
GERMAN FEDERAL MINISTRY FOR EDUCATION AND RESEARCH
DEUTSCHE DIABETES-UNION
PHARMA PRIVAT
BAH, BUNDESVERBAND DER ARZNEIMITTEL-HERSTELLER E.V.
VFA, THE GERMAN ASSOCIATION OF RESEARCH-BASED PHARMACEUTICAL COMPANIES
COMPANY PROFILES: GERMANY
CELESIO AG
MERCK KGAA
SANDOZ
STADA ARZNEIMITTEL AG

Chapter- 11: UNITED KINGDOM (U.K.)

INTRODUCTION
TABLE 79 OVERALL PHARMACEUTICAL MARKET, U.K., THROUGH 2013 ($ BILLIONS)
DRIVERS OF PHARMACEUTICAL SALES GROWTH
POPULATION AND DEMOGRAPHICS
TABLE 80 POPULATION TRENDS, U.K., THROUGH 2013 (MILLIONS)
FIGURE 13 U.K. POPULATION, 1998-2013 (MILLIONS)
TABLE 81 DEMOGRAPHIC TRENDS, U.K., THROUGH 2013 (MILLIONS)
THE U.K. HEALTHCARE SYSTEM
HEALTHCARE EXPENDITURE IN THE U.K.
TABLE 82 HEALTHCARE EXPENDITURE: U.K., 2000-2005
COMMON HEALTH PROBLEMS IN THE U.K.
ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS
TABLE 83 PREVALENCE OF DEMENTIA IN THE U.K. 2005-2050 (MILLIONS OF PEOPLE)
OBESITY AND RELATED CONDITIONS
DIABETES
CARDIOVASCULAR DISEASE (INCLUDING HEART DISEASE AND STROKE)
TABLE 84 PERCENTAGE OF PRESCRIPTION OF PHARMACEUTICALS BY TOP EIGHT CLASSES, U.K., 2006 (%)
TABLE 85 PERCENTAGE OF PRESCRIPTION OF PHARMACEUTICALS, BY CLASS, U.K., 2006 ($ MILLIONS)
BARRIERS TO PHARMACEUTICAL REVENUE GROWTH IN THE U.K. AND REVENUE BREAKDOWN
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 86 BRANDED PHARMACEUTICAL MARKET, U.K., THROUGH 2013 ($ BILLIONS)
TABLE 87 LEADING PHARMACEUTICAL COMPANIES, U.K., 2004 (% OF TOTAL MARKET)
GENERIC DRUGS
TABLE 88 GENERIC PHARMACEUTICAL MARKET, U.K., THROUGH 2013 ($ BILLIONS)
DRIVERS AND RESTRAINTS
OVER-THE-COUNTER (OTC) MEDICATIONS IN THE U.K.
TABLE 89 OTC PHARMACEUTICAL MARKET, U.K., THROUGH 2013 ($ BILLIONS)
TABLE 90 LEADING OTC CATEGORIES, 2006, U.K. (% OF TOTAL MARKET)
EXPORT--IMPORT PROFILE
TABLE 91 PHARMACEUTICAL EXPORTS--IMPORTS, U.K., 1997--2006 ($ BILLIONS)
PHARMACEUTICAL DISTRIBUTION
WHOLESALERS
TABLE 92 LEADING PHARMACEUTICAL DISTRIBUTORS, U.K. (% OF TOTAL MARKET)
U.K.'S PHARMACEUTICAL EXPORTS AND IMPORTS IN POUNDS STERLING
TABLE 93 PHARMACEUTICAL EXPORTS, U.K., 1997-2006 (₤ BILLIONS)
IMPORTANT ORGANIZATIONS IN THE U.K.
NATIONAL STATISTICS U.K.
ABPI, THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY
THE BRITISH ASSOCIATION OF PHARMACEUTICAL WHOLESALERS (BAPW)
COMPANY PROFILES: U.K.
AAH PHARMACEUTICALS
GLAXOSMITHKLINE (GSK)
MAWDSLEY-BROOKS & CO. LTD.
PHOENIX HEALTHCARE DISTRIBUTION, LTD.
UNICHEM

Chapter- 12: ITALY

INTRODUCTION
TABLE 94 OVERALL PHARMACEUTICAL MARKET, ITALY, THROUGH 2013 ($ BILLIONS)
DRIVERS OF PHARMACEUTICAL SALES GROWTH
POPULATION AND DEMOGRAPHICS
TABLE 95 POPULATION TRENDS, ITALY, THROUGH 2013 (MILLIONS)
FIGURE 14 ITALY: POPULATION, 1998-2013 (MILLIONS)
TABLE 96 DEMOGRAPHIC TRENDS, ITALY, THROUGH 2013 (MILLIONS)
THE ITALIAN HEALTHCARE SYSTEM AND GROWTH DRIVERS
TABLE 97 HEALTHCARE EXPENDITURE: ITALY, 2000-2005
COMMON HEALTH PROBLEMS IN ITALY
ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS
OBESITY AND RELATED CONDITIONS
DIABETES
CARDIOVASCULAR DISEASE (INCLUDING HEART DISEASE AND STROKE)
TABLE 98 PERCENTAGE OF CLASS C PRESCRIPTION PHARMACEUTICALS BY CLASS, ITALY, 2006 (%)
BARRIERS TO PHARMACEUTICAL REVENUE GROWTH IN ITALY
REVENUE BREAKDOWN OF PHARMACEUTICAL PRODUCTS IN ITALY
FIGURE 15 VALUE BREAKDOWN OF PHARMACEUTICALS, ITALY, 2005 (%)
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 99 BRANDED PHARMACEUTICAL MARKET, ITALY, THROUGH 2013 ($ BILLIONS)
GENERIC DRUGS
TABLE 100 GENERIC PHARMACEUTICAL MARKET, ITALY, THROUGH 2013 ($ BILLIONS)
DRIVERS AND RESTRAINTS
OVER-THE-COUNTER MEDICATIONS
TABLE 101 OTC PHARMACEUTICAL MARKET, ITALY, THROUGH 2013 ($ BILLIONS)
TABLE 102 LEADING OTC CATEGORIES, ITALY, 2006 (% OF TOTAL MARKET)
EXPORT--IMPORT PROFILE
TABLE 103 PHARMACEUTICAL EXPORTS, ITALY, 2005 AND 2006 ($ BILLIONS, ROUNDED)
TABLE 104 LEADING DESTINATIONS OF ITALIAN PHARMACEUTICAL EXPORTS, 2006 (% OF TOTAL MARKET)
TABLE 105 PHARMACEUTICAL IMPORTS, ITALY, 2005 AND 2006 ($ BILLIONS)
TABLE 106 LEADING DESTINATIONS OF ITALIAN PHARMACEUTICAL IMPORTS, 2006 (% OF TOTAL MARKET)
ITALY'S PHARMACEUTICAL EXPORTS AND IMPORTS IN EUROS
TABLE 107 PHARMACEUTICAL EXPORTS, ITALY, 2005 AND 2006 (EUR BILLIONS)
TABLE 108 PHARMACEUTICAL IMPORTS, ITALY, 2005 AND 2006 (EUR BILLIONS)
IMPORTANT ORGANIZATIONS IN ITALY
NATIONAL INSTITUTE FOR STATISTICS (ISTITUTO NAZIONALE DI STATISTICA)
FARMINDUSTRIA, THE PHARMACEUTICAL MANUFACTURER'S ASSOCIATION OF ITALY
ASSOGENERICI, THE ITALIAN NATIONAL ASSOCIATION OF GENERIC PHARMACEUTICALS

Chapter- 13: SPAIN

INTRODUCTION
TABLE 109 OVERALL PHARMACEUTICAL MARKET, SPAIN, THROUGH 2013 ($ BILLIONS)
DRIVERS OF PHARMACEUTICAL SALES GROWTH
POPULATION AND DEMOGRAPHICS
TABLE 110 POPULATION TRENDS, SPAIN, THROUGH 2013 (MILLIONS)
FIGURE 16 SPAIN: POPULATION, 1998-2013 (MILLIONS)
TABLE 111 DEMOGRAPHIC TRENDS, SPAIN, THROUGH 2013 (MILLIONS)
THE SPANISH HEALTHCARE SYSTEM, PRICING, AND PHARMACEUTICAL GROWTH DRIVERS
THE HEALTHCARE SYSTEM
TABLE 112 HEALTHCARE EXPENDITURE: SPAIN, 2000-2005
DRUG PRICING POLICIES
COMMON HEALTH PROBLEMS IN SPAIN
ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS
OBESITY AND RELATED CONDITIONS
DIABETES
CARDIOVASCULAR DISEASE (INCLUDING HEART DISEASE AND STROKE)
TABLE 113 PERCENTAGE OF PRESCRIPTION OF PHARMACEUTICALS, BY CLASS, SPAIN, 2006
GROWTH DRIVERS
BARRIERS TO PHARMACEUTICAL REVENUE GROWTH IN SPAIN
REVENUE BREAKDOWN OF PHARMACEUTICAL PRODUCTS IN SPAIN
FIGURE 17 VALUE BREAKDOWN OF PHARMACEUTICALS, SPAIN, 2005 (%)
MARKET SECTORS
BRANDED PRESCRIPTION PHARMACEUTICALS
TABLE 114 BRANDED PHARMACEUTICAL MARKET, SPAIN, THROUGH 2013 ($ BILLIONS)
GENERIC DRUGS
TABLE 115 GENERIC PHARMACEUTICAL MARKET, SPAIN, THROUGH 2013 ($ BILLIONS)
DRIVERS AND RESTRAINTS
OVER-THE-COUNTER MEDICATIONS
TABLE 116 OTC PHARMACEUTICAL MARKET, SPAIN, THROUGH 2013 ($ MILLIONS)
EXPORT--IMPORT PROFILE
TABLE 117 PHARMACEUTICAL EXPORTS, SPAIN, 2005 AND 2006 (%)
TABLE 118 PHARMACEUTICAL IMPORTS, SPAIN, 2005 AND 2006 (%)
IMPORTANT ORGANIZATIONS IN SPAIN
NATIONAL STATISTICS INSTITUTE (INSTITUTO NACIONAL DE ESTADISTICA)
FARMAINDUSTRIA, THE NATIONAL ASSOCIATION OF THE PHARMACEUTICAL INDUSTRY IN SPAIN
AESEG, THE SPANISH ASSOCIATION OF GENERIC PHARMACEUTICALS MANUFACTURERS
ANEFP, THE NATIONALS ASSOCIATION OF OVER-THE-COUNTER MEDICATIONS
CEAFA, CONFEDERACTION ESPANOLA DE FAMILIARES ENFERMOS DE ALZHEIMER'S Y OTRAS DEMENCIAS

Chapter- 14: SMALLER PHARMACEUTICAL MARKETS IN EUROPE

GREECE
INTRODUCTION
TABLE 119 OVERALL PHARMACEUTICAL MARKET, GREECE, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 120 POPULATION TRENDS, GREECE, THROUGH 2013 (MILLIONS)
FIGURE 18 GREECE: POPULATION, 1998-2013
(MILLIONS)
TABLE 121 DEMOGRAPHIC TRENDS, GREECE, THROUGH 2013 (MILLIONS)
THE GREEK HEALTHCARE SYSTEM
Structure of the Healthcare System
Healthcare Expenditures
TABLE 122 HEALTHCARE EXPENDITURE: GREECE, 2000-2005
COMMON HEALTH PROBLEMS IN GREECE
Pharmaceutical Pricing
TABLE 123 PERCENTAGE OF PRESCRIPTION PHARMACEUTICALS, BY CLASS, GREECE, 2004
REVENUE BREAKDOWN OF PHARMACEUTICAL PRODUCTS IN GREECE
FIGURE 19 VALUE BREAKDOWN OF PHARMACEUTICALS, GREECE, 2005 (%)
Growth Drivers
Barriers to Pharmaceutical Revenue Growth in Greece
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 124 BRANDED PHARMACEUTICAL MARKET, GREECE, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 125 GENERIC PHARMACEUTICAL MARKET, GREECE, THROUGH 2013 ($ BILLIONS)
Drivers and Restraints
Over-the-Counter Medications
TABLE 126 OTC PHARMACEUTICAL MARKET, GREECE, THROUGH 2013 ($ MILLIONS)
TABLE 127 LEADING OTC CATEGORIES, GREECE, 2006 (% OF TOTAL MARKET)
IMPORTANT ORGANIZATIONS IN GREECE
STATISTICS GREECE
THE HELLENIC ASSOCIATION OF PHARMACEUTICAL COMPANIES (SFEE)
EFEX, THE GREEK PROPRIETARY ASSOCIATION
THE NETHERLANDS
INTRODUCTION
TABLE 128 OVERALL PHARMACEUTICAL MARKET, NETHERLANDS, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 129 POPULATION TRENDS, NETHERLANDS, THROUGH 2013 (MILLIONS)
FIGURE 20 NETHERLANDS: POPULATION, 1998-2013 (MILLIONS)
TABLE 130 DEMOGRAPHIC TRENDS, NETHERLANDS, THROUGH 2013 (MILLIONS)
THE DUTCH HEALTHCARE SYSTEM
Structure of the Healthcare System
Healthcare Expenditures
TABLE 131 HEALTHCARE EXPENDITURE: THE NETHERLANDS, 2000-2005
COMMON HEALTH PROBLEMS IN THE NETHERLANDS
Drug Pricing
REVENUE BREAKDOWN OF PHARMACEUTICAL PRODUCTS IN THE NETHERLANDS
FIGURE 21 VALUE BREAKDOWN OF PHARMACEUTICALS, NETHERLANDS, 2005 (%)
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 132 BRANDED PHARMACEUTICAL MARKET, NETHERLANDS, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 133 GENERIC PHARMACEUTICAL MARKET, NETHERLANDS, THROUGH 2013 ($ BILLIONS)
Drivers and Restraints
Over-the-Counter Medications
TABLE 134 OTC PHARMACEUTICAL MARKET, NETHERLANDS, THROUGH 2013 ($ MILLIONS)
TABLE 135 LEADING OTC CATEGORIES, NETHERLANDS, 2006 (% OF TOTAL MARKET)
IMPORTANT ORGANIZATIONS IN THE NETHERLANDS
STATISTICS NETHERLANDS
NEFARMA, THE ASSOCIATION OF INNOVATE PHARMACEUTICALS IN THE NETHERLANDS
BOGIN, THE ASSOCIATION OF DUTCH GENERIC MEDICATIONS INDUSTRY
NEPROPHARM, THE NETHERLANDS ASSOCIATION OF OVER-THE-COUNTER PRODUCTS
BELGIUM
INTRODUCTION
TABLE 136 OVERALL PHARMACEUTICAL MARKET, BELGIUM, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 137 POPULATION TRENDS, BELGIUM, THROUGH 2013 (MILLIONS)
FIGURE 22 BELGIUM: POPULATION, 1998-2013 (MILLIONS)
TABLE 138 DEMOGRAPHIC TRENDS, BELGIUM, THROUGH 2013 (MILLIONS)
THE BELGIAN HEALTHCARE SYSTEM
Structure of the Healthcare System
TABLE 139 HEALTHCARE EXPENDITURE: BELGIUM, 2000-2005
COMMON HEALTH PROBLEMS IN BELGIUM
DRUG PRICING
REVENUE BREAKDOWN OF PHARMACEUTICAL PRODUCTS IN BELGIUM
FIGURE 23 VALUE BREAKDOWN OF PHARMACEUTICALS, BELGIUM, 2005 (%)
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 140 BRANDED PHARMACEUTICAL MARKET, BELGIUM, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 141 GENERIC PHARMACEUTICAL MARKET, BELGIUM, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 142 OTC PHARMACEUTICAL MARKET, BELGIUM, THROUGH 2013 ($ MILLIONS)
TABLE 143 LEADING OTC CATEGORIES, BELGIUM, 2006 (% OF TOTAL MARKET)
IMPORTANT ORGANIZATIONS IN BELGIUM
STATISTICS BELGIUM
PHARMA.BE, THE GENERAL ASSOCIATION OF THE MEDICINES INDUSTRY
EUROGENERICS
POLAND
INTRODUCTION
TABLE 144 OVERALL PHARMACEUTICAL MARKET, POLAND, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 145 POPULATION TRENDS, POLAND, THROUGH 2013 (MILLIONS)
FIGURE 24 POLAND: POPULATION, 1998-2013 (MILLIONS)
TABLE 146 DEMOGRAPHIC TRENDS, POLAND, THROUGH 2013 (MILLIONS)
COMMON HEALTH PROBLEMS IN POLAND
THE POLISH HEALTHCARE SYSTEM
Structure of the Healthcare System
TABLE 147 HEALTHCARE EXPENDITURE: POLAND, 2000-2005
DRUG PRICING
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 148 BRANDED PHARMACEUTICAL MARKET, POLAND, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 149 GENERIC PHARMACEUTICAL MARKET, POLAND, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 150 OTC PHARMACEUTICAL MARKET, POLAND, THROUGH 2013 ($ MILLIONS)
TABLE 151 LEADING OTC CATEGORIES, POLAND, 2006 (% OF TOTAL MARKET)
IMPORTANT ORGANIZATIONS IN POLAND
POLISH CENTRAL STATISTICS OFFICE
POLFARMED, POLISH CHAMBER OF PHARMACEUTICALS INDUSTRY AND MEDICAL DEVICES
PASMI, THE POLISH ASSOCIATION OF THE SELF-MEDICATION INDUSTRY
PORTUGAL
INTRODUCTION
TABLE 152 OVERALL PHARMACEUTICAL MARKET, PORTUGAL, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 153 POPULATION TRENDS, PORTUGAL, THROUGH 2013 (MILLIONS)
FIGURE 25 PORTUGAL: POPULATION, 1998-2013 (MILLIONS)
TABLE 154 DEMOGRAPHIC TRENDS, PORTUGAL, THROUGH 2013 (MILLIONS)
THE PORTUGUESE HEALTHCARE SYSTEM
Structure of the Healthcare System
TABLE 155 HEALTHCARE EXPENDITURE: PORTUGAL, 2000-2005
Pharmaceutical Pricing
FIGURE 26 VALUE BREAKDOWN OF PHARMACEUTICALS, PORTUGAL, 2005 (%)
COMMON HEALTH PROBLEMS IN PORTUGAL
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 156 BRANDED PHARMACEUTICAL MARKET, PORTUGAL, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 157 GENERIC PHARMACEUTICAL MARKET, PORTUGAL, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 158 OTC PHARMACEUTICAL MARKET, PORTUGAL, THROUGH 2013 ($ MILLIONS)
TABLE 159 LEADING OTC CATEGORIES, PORTUGAL, 2006 (% OF TOTAL MARKET)
IMPORTANT ORGANIZATIONS IN PORTUGAL
STATISTICS PORTUGAL
APOGEN, PORTUGUESE ASSOCIATION OF GENERIC MEDICATIONS
APIFARMA, THE ASSOCIATION OF THE PORTUGUESE PHARMACEUTICAL INDUSTRY
SWITZERLAND
INTRODUCTION
TABLE 160 OVERALL PHARMACEUTICAL MARKET, SWITZERLAND, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 161 POPULATION TRENDS, SWITZERLAND, THROUGH 2013 (MILLIONS)
FIGURE 27 SWITZERLAND: POPULATION, 1998-2013 (MILLIONS)
TABLE 162 DEMOGRAPHIC TRENDS, SWITZERLAND, THROUGH 2013 (MILLIONS)
Common Health Problems in Switzerland
THE SWISS HEALTHCARE SYSTEM
Structure of the Healthcare System
TABLE 163 HEALTHCARE EXPENDITURE: SWITZERLAND, 2000-2005
Pharmaceutical Environment and Pricing
FIGURE 28 VALUE BREAKDOWN OF PHARMACEUTICALS, SWITZERLAND, 2005 (%)
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 164 BRANDED PHARMACEUTICAL MARKET, SWITZERLAND, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 165 GENERIC PHARMACEUTICAL MARKET, SWITZERLAND, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 166 OTC PHARMACEUTICAL MARKET, SWITZERLAND, THROUGH 2013 ($ MILLIONS)
TABLE 167 LEADING OTC CATEGORIES, SWITZERLAND, 2006 (% OF TOTAL MARKET)
IMPORTANT ORGANIZATIONS IN SWITZERLAND
SWISS FEDERAL STATISTICS OFFICE
COMPANY PROFILES
NOVARTIS INTERNATIONAL AG
SWEDEN
INTRODUCTION
TABLE 168 OVERALL PHARMACEUTICAL MARKET, SWEDEN, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 169 POPULATION TRENDS, SWEDEN, THROUGH 2013 (MILLIONS)
FIGURE 29 SWEDEN: POPULATION, 1998-2013 (MILLIONS)
TABLE 170 DEMOGRAPHIC TRENDS, SWEDEN, THROUGH 2013 (MILLIONS)
HEALTH PROBLEMS AND HEALTHCARE IN SWEDEN
The Healthcare System
TABLE 171 HEALTHCARE EXPENDITURE: SWEDEN, 2000-2005
Pharmaceutical Pricing
FIGURE 30 VALUE BREAKDOWN OF PHARMACEUTICALS, SWEDEN, 2005 (%)
Health Problems in Sweden
TABLE 172 LEADING THERAPEUTIC CATEGORIES, SWEDEN, 2006 (% OF TOTAL MARKET, BY VALUE)
MARKET SECTORS
Branded Pharmaceuticals
TABLE 173 BRANDED PHARMACEUTICAL MARKET, SWEDEN, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 174 GENERIC PHARMACEUTICAL MARKET, SWEDEN, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 175 OTC PHARMACEUTICAL MARKET, SWEDEN, THROUGH 2013 ($ MILLIONS)
IMPORTANT ORGANIZATIONS IN SWEDEN
STATISTICS SWEDEN
FGL, THE SWEDISH ASSOCIATION FOR GENERIC PHARMACEUTICALS
AUSTRIA
INTRODUCTION
TABLE 176 OVERALL PHARMACEUTICAL MARKET, AUSTRIA, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 177 POPULATION TRENDS, AUSTRIA, THROUGH 2013 (MILLIONS)
FIGURE 31 AUSTRIA: POPULATION, 1998-2013 (MILLIONS)
TABLE 178 DEMOGRAPHIC TRENDS, AUSTRIA, THROUGH 2013 (MILLIONS)
HEALTHCARE AND HEALTH PROBLEMS IN AUSTRIA
The Healthcare System
Pharmaceutical Pricing
TABLE 179 HEALTHCARE EXPENDITURE: AUSTRIA, 2000-2005
Health Problems in Austria
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 180 BRANDED PHARMACEUTICAL MARKET, AUSTRIA, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 181 GENERIC PHARMACEUTICAL MARKET, AUSTRIA, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 182 OTC PHARMACEUTICAL MARKET, AUSTRIA, THROUGH 2013 ($ MILLIONS)
IMPORTANT ORGANIZATIONS IN AUSTRIA
STATISTICS AUSTRIA
PHARMIG, THE
IGEPHA, THE AUSTRIAN SELF-MEDICATION INDUSTRY
HUNGARY
INTRODUCTION
TABLE 183 OVERALL PHARMACEUTICAL MARKET, HUNGARY, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
HEALTH PROBLEMS AND HEALTHCARE IN HUNGARY
The Healthcare System
Pharmaceutical Pricing
Health Problems in Hungary
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 184 BRANDED PHARMACEUTICAL MARKET, HUNGARY, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 185 GENERIC PHARMACEUTICAL MARKET, HUNGARY, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 186 OTC PHARMACEUTICAL MARKET, HUNGARY, THROUGH 2013 ($ MILLIONS)
IMPORTANT ORGANIZATIONS IN HUNGARY
HUNGARIAN CENTRAL STATISTICS OFFICE
MAGYOSZ, THE HUNGARIAN PHARMACEUTICAL MANUFACTURERS ASSOCIATION
FINLAND
INTRODUCTION
TABLE 187 OVERALL PHARMACEUTICAL MARKET, FINLAND, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 188 POPULATION TRENDS, FINLAND, THROUGH 2013 (MILLIONS)
TABLE 189 DEMOGRAPHIC TRENDS, FINLAND, THROUGH 2013 (MILLIONS)
HEALTH PROBLEMS AND HEALTHCARE IN FINLAND
The Healthcare System
PHARMACEUTICAL PRICING
Health Problems in Finland
MARKET SECTORS
TABLE 190 LEADING THERAPEUTIC CATEGORIES, FINLAND, 2006 (% OF TOTAL MARKET, BY VALUE)
Branded Prescription Pharmaceuticals
TABLE 191 BRANDED PHARMACEUTICAL MARKET, FINLAND, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 192 GENERIC PHARMACEUTICAL MARKET, FINLAND, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 193 OTC PHARMACEUTICAL MARKET, FINLAND, THROUGH 2013 ($ MILLIONS)
IMPORTANT ORGANIZATIONS IN FINLAND
STATISTICS FINLAND
IMPORTANT ORGANIZATIONS IN EUROPE
THE EUROPEAN FEDERATION OF PHARMACEUTICAL INDUSTRIES AND ASSOCIATIONS (EFPIA)
THE EUROPEAN GENERICS ASSOCIATION (EGA)
THE ASSOCIATION OF THE EUROPEAN SELF-MEDICATION INDUSTRY (AESGP)

Chapter- 15: ASIA

JAPAN
INTRODUCTION
TABLE 194 OVERALL PHARMACEUTICAL MARKET, JAPAN, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 195 POPULATION TRENDS, JAPAN, THROUGH 2013 (MILLIONS)
TABLE 196 DEMOGRAPHIC TRENDS, JAPAN, THROUGH 2013 (MILLIONS)
FIGURE 32 JAPAN: POPULATION, 1998-2013 (MILLIONS)
THE JAPANESE HEALTHCARE SYSTEM
Healthcare Expenditures in Japan
TABLE 197 HEALTHCARE EXPENDITURE: JAPAN, 2000-2005
Common Health Problems in Japan
TABLE 198 LEADING CAUSES OF DEATH, JAPAN, 2005
Cancer
TABLE 199 LEADING FORMS OF CANCER, JAPAN, 2005
Alzheimer's Disease and Related Dementias
Obesity and Diabetes
Cardiovascular Disease
Smoking
PHARMACEUTICAL PRICING
Pricing of Generic Drugs
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 120 BRANDED PHARMACEUTICAL MARKET, JAPAN, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 201 GENERIC PHARMACEUTICAL MARKET, JAPAN, THROUGH 2013 ($ BILLIONS)
OVER-THE-COUNTER MEDICATIONS IN JAPAN
TABLE 202 OTC PHARMACEUTICAL MARKET, JAPAN, THROUGH 2013 ($ BILLIONS)
TABLE 203 LEADING OTC CATEGORIES, JAPAN
IMPORTANT ORGANIZATIONS IN JAPAN
STATISTICS BUREAU
MINISTRY OF HEALTH, LABOUR, & WELFARE
JPMA, JAPAN PHARMACEUTICAL MANUFACTURER'S ASSOCIATION
JSMI, JAPANESE SELF-MEDICATION INDUSTRY
COMPANY PROFILES
ASTELLAS PHARMA
SAWAI PHARMACEUTICAL COMPANY LTD.
TAKEDA PHARMACEUTICAL COMPANY LTD.
CHINA
INTRODUCTION
TABLE 204 OVERALL PHARMACEUTICAL MARKET, CHINA, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 205 POPULATION TRENDS, CHINA, THROUGH 2013 (MILLIONS)
TABLE 206 DEMOGRAPHIC TRENDS, CHINA, THROUGH 2013 (MILLIONS)
HEALTHCARE AND HEALTH PROBLEMS IN CHINA
The Healthcare System
Pharmaceutical Pricing
Health Problems in China
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 207 PRESCRIPTION PHARMACEUTICAL MARKET, CHINA, THROUGH 2013 ($ BILLIONS)
Generic Drugs
Over-the-Counter Medications
TABLE 208 OTC PHARMACEUTICAL MARKET, CHINA, THROUGH 2013 ($ MILLIONS)
IMPORTANT ORGANIZATIONS IN CHINA
NATIONAL BUREAU OF STATISTICS OF CHINA
SOUTH KOREA
INTRODUCTION
TABLE 209 OVERALL PHARMACEUTICAL MARKET, SOUTH KOREA, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 210 POPULATION TRENDS, SOUTH KOREA, THROUGH 2013 (MILLIONS)
TABLE 211 DEMOGRAPHIC TRENDS, SOUTH KOREA, THROUGH 2013 (MILLIONS)
HEALTHCARE AND HEALTH PROBLEMS IN SOUTH KOREA
The Healthcare System
Pharmaceutical Pricing
Health Problems in South Korea
TABLE 212 LEADING CAUSES OF DEATH, SOUTH KOREA, 2003
MARKET SECTORS
Branded and Generic Prescription Pharmaceuticals
TABLE 213 PRESCRIPTION PHARMACEUTICAL MARKET, SOUTH KOREA, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 214 OTC PHARMACEUTICAL MARKET, SOUTH KOREA, THROUGH 2013 ($ MILLIONS)
IMPORTANT ORGANIZATIONS IN SOUTH KOREA
KOREAN NATIONAL STATISTICAL OFFICE
AUSTRALIA
INTRODUCTION
TABLE 215 OVERALL PHARMACEUTICAL MARKET, AUSTRALIA, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 216 POPULATION TRENDS, AUSTRALIA, THROUGH 2013 (MILLIONS)
HEALTHCARE AND HEALTH PROBLEMS IN AUSTRALIA
The Healthcare System (Medicare)
Pharmaceutical Pricing
Health Problems in Australia
TABLE 217 LEADING CAUSES OF DEATH, MEN, AUSTRALIA, 2005 (% OF ALL DEATHS)
TABLE 218 LEADING CAUSES OF DEATH, WOMEN, AUSTRALIA, 2004 (% OF ALL DEATHS)
TABLE 219 COMMON CHRONIC CONDITIONS, AUSTRALIA, 2005 (% OF POPULATION)
MARKET SECTORS
Branded Prescription Pharmaceuticals
TABLE 220 BRANDED PHARMACEUTICAL MARKET, AUSTRALIA, THROUGH 2013 ($ BILLIONS)
Generic Drugs
TABLE 221 GENERIC PHARMACEUTICAL MARKET, AUSTRALIA, THROUGH 2013 ($ BILLIONS)
Over-the-Counter Medications
TABLE 222 OTC PHARMACEUTICAL MARKET, AUSTRALIA, THROUGH 2013 ($ MILLIONS)
TABLE 223 TOP OTC PURCHASES, AUSTRALIA (% OF THE POPULATION)
IMPORTANT ORGANIZATIONS IN AUSTRALIA
AUSTRALIAN BUREAU OF STATISTICS
DEPARTMENT OF INNOVATION, INDUSTRY, SCIENCE, AND RESEARCH
MEDICINES AUSTRALIA
INDIA
INTRODUCTION
TABLE 224 OVERALL PHARMACEUTICAL MARKET, INDIA, THROUGH 2013 ($ BILLIONS)
POPULATION AND DEMOGRAPHICS
TABLE 225 POPULATION TRENDS, INDIA, THROUGH 2013 (MILLIONS)
HEALTHCARE AND HEALTH PROBLEMS IN INDIA
Pharmaceutical Pricing
HEALTH PROBLEMS IN INDIA
MARKET SECTORS
Overview
TABLE 226 TOP INDIAN PHARMACEUTICAL COMPANIES BY REVENUES, 2006 ($ MILLIONS)
Barriers to Growth in India
Branded Prescription Pharmaceuticals
TABLE 227 PRESCRIPTION PHARMACEUTICAL MARKET, INDIA, THROUGH 2013 ($ BILLIONS)
Generics
Over-the-Counter Medications
TABLE 228 OTC PHARMACEUTICAL MARKET, INDIA, THROUGH 2013 ($ BILLIONS)
IMPORTANT ORGANIZATIONS IN INDIA
MINISTRY OF STATISTICS AND PROGRAMME IMPLEMENTATION
MINISTRY OF HEALTH
IDMA, THE INDIAN DRUG MANUFACTURERS ASSOCIATION
OPPI, THE ORGANISATION OF PHARMACEUTICAL PRODUCERS OF INDIA
COMPANY PROFILES
RANBAXY LABORATORIES, LTD
CIPLA LTD.
DR. REDDY'S LABORATORIES LTD.
SOME INTERESTING LINKS RELATED TO HEALTH, PHARMACEUTICALS, AND DISEASE
PHARMACEUTICAL MARKETS IN SELECTED COUNTRIES NOT COVERED IN DETAIL IN THIS REPORT
SOME INTERESTING LINKS RELATED TO HEALTH, PHARMACEUTICALS, AND DISEASE